BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/13/2023 8:46:32 AM | Browse: 695 | Download: 1707
Publication Name World Journal of Gastroenterology
Manuscript ID 84675
Country Russia
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota
Manuscript Source Invited Manuscript
All Author List Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov and Vladimir Ivashkin
ORCID
Author(s) ORCID Number
Roman Maslennikov http://orcid.org/0000-0001-7513-1636
Aliya Alieva http://orcid.org/0000-0002-7606-2246
Elena Poluektova http://orcid.org/0000-0002-9038-3732
Yury Zharikov http://orcid.org/0000-0001-9636-3807
Andrey Suslov http://orcid.org/0000-0003-0613-8556
Yana Letyagina http://orcid.org/0009-0003-0491-5179
Evgenii Kozlov http://orcid.org/0000-0001-6244-1088
Vladimir Ivashkin http://orcid.org/0000-0002-6815-6015
Funding Agency and Grant Number
Corresponding Author Roman Maslennikov, MD, PhD, Academic Editor, Assistant Professor, Doctor, Doctor, Professor, Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Pogodinskaya str., 1, bld. 1, Moscow 119435, Russia. mmmm00@yandex.ru
Key Words Cirrhosis; Muscle; Fragility; Liver; Microbiota; Microbiome
Core Tip Sarcopenia is common in patients with cirrhosis and is associated with a poor prognosis. Although the pathogenesis of this disorder has not been fully elucidated, a disordered gut-muscle axis probably plays an important role. Drugs that target the gut microbiota positively affect most links of the compromised gut-muscle axis in patients with cirrhosis. However, they have not yet been investigated in randomized controlled trials specifically for the treatment and prevention of sarcopenia in patients with cirrhosis.
Publish Date 2023-07-13 08:46
Citation Maslennikov R, Alieva A, Poluektova E, Zharikov Y, Suslov A, Letyagina Y, Vasileva E, Levshina A, Kozlov E, Ivashkin V. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World J Gastroenterol 2023; 29(27): 4236-4251
URL https://www.wjgnet.com/1007-9327/full/v29/i27/4236.htm
DOI https://dx.doi.org/10.3748/wjg.v29.i27.4236
Full Article (PDF) WJG-29-4236-with-cover.pdf
Full Article (Word) WJG-29-4236.docx